About the study
This Phase 2a study is evaluating SAR445399, an investigational treatment, compared with placebo in adults with non-cystic fibrosis bronchiectasis. The main measure is the change in mucus plugging of the airways seen on a high-resolution chest CT scan after 24 weeks. Lung function and flare-ups of bronchiectasis are also tracked.
Who took part
The study enrolled people who:
- Were 18 to 80 years old
- Had bronchiectasis confirmed on chest CT, with daily mucus production
- Had at least 2 flare-ups treated with antibiotics in the prior year
Status at Veritas
This study is active but no longer enrolling new participants. People already enrolled continue their study visits.
Learn more
The full study record, including all eligibility criteria and outcome measures, is on ClinicalTrials.gov (NCT07547436).